Melt Pharmaceuticals, Inc. — Form D/A

Melt Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2024-03-11. The offering totals $47.8M, of which $41.6M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2024-03-11
• Form: D/A
• Accession: 0001767398-24-000003
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $47.8M
• Amount sold: $41.6M
• Remaining: $6.2M
• Investors: 300
• Date of first sale: 2023-07-28
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-489452

Issuer

• Name: Melt Pharmaceuticals, Inc.
• CIK: 0001767398
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 12264 EL CAMINO REAL, SUITE 350 12264 El Camino Real, Suite 350, SAN DIEGO, CA, 92130
• Phone: 8587044042

Officers, directors & promoters (13)

Other filings by this issuer (10)

More

• CIK 1767398 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search